Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 1999 Dec 20;13(6):251–258. doi: 10.1002/(SICI)1098-2825(1999)13:6<251::AID-1>3.0.CO;2-7

Effects of Ava II and Hinc II polymorphisms at the LDL receptor gene on serum lipid levels of Brazilian individuals with high risk for coronary heart disease

Luis A Salazar 1,✉, Mario H Hirata 1, Sérgio D Giannini 2, Neusa Forti 2, Jayme Diament 2, Jaqueline S Issa 2, Rosario DC Hirata 1
PMCID: PMC6808152  PMID: 10633291

Abstract

Coronary heart disease (CHD) has presented high prevalence in the Brazilian population. Nevertheless, studies of genetic risk factors for CHD in our country are insufficiently carried out. We have investigated the effects of Ava II (exon 13) and Hinc II (exon 12) polymorphisms at the low‐density lipoprotein receptor (LDLR) gene on circulating lipids of 170 white unrelated individuals presenting a lipid profile with high risk for CHD (HRG) and 130 controls (CG) from São Paulo City, Brazil. Ava II and Hinc II polymorphic regions at the LDLR gene were amplified by PCR and analyzed by enzymatic isotyping. The frequency of the genotypes A+A+ (Ava II) and H+H+ (Hinc II) was greater in HRG group compared to that of the controls (32 vs. 16% and 32 vs. 18%, respectively). Moreover, in the HRG group, A+A+ and H+H+ genotypes were associated with high concentrations of total cholesterol and LDL‐C in serum (P = 0.0001). Our results indicate that Ava II and Hinc II polymorphisms at the LDLR locus contribute to the variability of total cholesterol and LDL‐C levels in HRG individuals. These data suggest that the LDLR polymorphism remains a useful genetic marker for predicting CHD risk. J. Clin. Lab. Anal. 13:251–258, 1999. © 1999 Wiley‐Liss, Inc.

Keywords: DNA polymorphism, low density lipoprotein receptor gene, serum cholesterol levels, genetic markers, cardiovascular disease

REFERENCES

  • 1. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986;57:5G–10G. Medline [DOI] [PubMed] [Google Scholar]
  • 2. Kane JP. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. J Am Med Assoc 1990;264:3007–3012. [PubMed] [Google Scholar]
  • 3. Castelli WP. Epidemiology of coronary heart disease: The Framingham study. Am J Med 1984;76:4–12. Medline [DOI] [PubMed] [Google Scholar]
  • 4. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from Coronary Heart Disease continuous and graded? Findings in 356.222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). J Am Med Assoc 1986;256:2823–2828. [PubMed] [Google Scholar]
  • 5. Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol 1995;76:69C–77C. Medline [DOI] [PubMed] [Google Scholar]
  • 6. Grundy SM, Veja GL, Kesáániemi Y. Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease. Acta Med Scand 1985;701:23–37. [DOI] [PubMed] [Google Scholar]
  • 7. Haberland ME, Fogelman AM. The role of altered lipoproteins in the pathogenesis of atherosclerosis. Am Heart J 1987;79:1712–1716. [DOI] [PubMed] [Google Scholar]
  • 8. Gylling H, Kontula K, Koivisto UM, Miettinen HE, Miettinen TA. Polymorphisms of the genes encoding apoproteins A‐I, B, C‐III and E and LDL receptor, and cholesterol and LDL metabolism during increase cholesterol intake . Common alleles of the apoprotein E gene show the greatest regulatory impact. Arterioscler Thromb Vasc Biol 1997;17:38–44. Medline [DOI] [PubMed] [Google Scholar]
  • 9. Galton DJ. Genetic determinants of atherosclerosis‐related dyslipidemias and their clinical implications. Clin Chim Acta 1997;257:181–197. Medline [DOI] [PubMed] [Google Scholar]
  • 10. Babaev VR, Dergunov AD, Chenchik AA, et al. Localization of apolipoprotein E in normal and artherosclerotic human aorta. Atherosclerosis 1990;85:239–247. Medline [DOI] [PubMed] [Google Scholar]
  • 11. Davignon J, Gregg RE, Sing CF. Apoliprotein E polymorphism and artherosclerosis. Arteriosclerosis 1988;8:1–21. Medline [DOI] [PubMed] [Google Scholar]
  • 12. Ferrieres J, Sing C, Roy M, Davignon J, Lussier‐Cacan S. Apolipoprotein E polymorphism and heterozygous familial hypercolesterlemia. Sex‐specific effects. Arterioscler Thromb Vasc Biol 1994;14:1553–1560. [DOI] [PubMed] [Google Scholar]
  • 13. Friedlander Y, Berry EM, Eisenberg S, Stein Y, Leitersdorf E. Plasma lipids and lipoproteins response to a dietary challenge: Analysis of four candidate genes. Clin Genet 1995;47:1–12. Medline [DOI] [PubMed] [Google Scholar]
  • 14. Berg K. DNA poymorphism at the apolipoprotein B locus associated with lipoprotein levels. Clin Genet 1986;30:515–520. Medline [DOI] [PubMed] [Google Scholar]
  • 15. Demant T, Houlston RS, Caslake MJ, et al. The catabolic rate of low density lipoprotein is influenced by variation in the apoliprotein B gene. J Clin Invest 1988;82:797–802. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Brown MS, Goldstein JL. A receptor‐mediated pathway for cholesterol homeostasis. Science 1986;232:34–47. Medline [DOI] [PubMed] [Google Scholar]
  • 17. Yamamoto T, Bishop RW, Brown MS, Goldstein JL, Russell DW. Deletion in cysteine‐rich protein region of LDL receptor impedes transport to cell surface in WHHL rabbit. Science 1986;232:1230–1237. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Südhof TC, Goldstein JL, Brown MS, Russell DW. The LDL receptor gene: A mosaic of exons shared with different proteins. Science 1985;228:815–822. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Humphries SE, Coviello DA, Masturzo P, Balestreri Jr, Orecchini G, Bertolini S. Variation in the low density lipoprotein receptor gene is associated with differences in plasma low density lipoprotein cholesterol levels in young and old normal individuals from Italy. Arterioscler Thromb 1991;11:509–516. Medline [DOI] [PubMed] [Google Scholar]
  • 20. Humphries SE, Kessling AM, Horsthemke B, et al. A common DNA polymorphism of the low‐density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet 1985;1:1003–1005. Medline [DOI] [PubMed] [Google Scholar]
  • 21. Humphries SE, King‐Underwood L, Gudnason V, et al. Six DNA polymorphisms in the low density lipoprotein receptor gene: Their genetic relationship and an example of their use for identifying affected relatives of patients witch familial hypercholesterolemia. J Med Genet 1993;30:273–279. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Hobbs H, Brown M, Goldstein J. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992;1:445–466. Medline [DOI] [PubMed] [Google Scholar]
  • 23. Pereira E, Pereira R, Hermelin B, et al. Recurrent and novel LDL receptor gene mutations causing heterozygous familial hypercholesterolemia in La Habana. Hum Genet 1995;96:319–322. Medline [DOI] [PubMed] [Google Scholar]
  • 24. Hobbs H, Leitersdorf E, Goldstein J, Brown M, Russell D. Multiple crm‐ mutations in familial hypercholesterolemia. evidence for 13 alleles, including four deletions. J Clin Invest 1988;81:909–917. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Levy E, Minnich A, Cacan, SL , et al. Association of an Exon 3 mutation (Trp66‐Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family. Biochem Mol Med 1997;60:59–69. Medline [DOI] [PubMed] [Google Scholar]
  • 26. Bertolini S, Coviello D, Masturzo P, et al. RFLPs of the LDL‐Receptor gene: Their use in the diagnosis of FH and evaluation of different levels of gene expression on normal subjects. Eur J Epidemiol 1992;8:18–25. Medline [DOI] [PubMed] [Google Scholar]
  • 27. Pedersen JC, Berg K. Normal DNA polymorphism at the low density lipoprotein receptor (LDLR) locus associated with serum cholesterol level. Clin Genet 1988;34:302–312. [DOI] [PubMed] [Google Scholar]
  • 28. Berkman N, Weir BS, Schwartz SP, Reshef A, Leitersdorf E. Haplotype analysis at the low density lipoprotein receptor locus: Application to the study of familial hypercholesterolemia in Israel. Hum Genet 1992;88:405–410. Medline [DOI] [PubMed] [Google Scholar]
  • 29. Ahn YI, Kamboh IM, Aston CE, Ferrell RE, Hamman RF. Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population. Arterioscler Thromb Vasc Biol 1994;14:663–670. [DOI] [PubMed] [Google Scholar]
  • 30. Wiseman SA, Powell JT, Humphries SE, Press M. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene. J Clin Endocrinol Metab 1993;77:108–112. Medline [DOI] [PubMed] [Google Scholar]
  • 31. Myant NB, Gallagher JJ, Knight BL, et al. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B‐100 and normal low density lipoprotein receptor function. Arterioscler Thromb 1991;11:691–703. Medline [DOI] [PubMed] [Google Scholar]
  • 32. Summary of the second report of the National Cholesterol Education Program‐NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J. Am Med Assoc 19934;269:3015–3023. [PubMed] [Google Scholar]
  • 33. Fossati P, Medicci R. Abstract book. International symposium on cholesterol control and cardiovascular diseases: Prevention and therapy. Milan, Italy, 1987. Tarrytown, NY: Apud, Bayer Corporation, Diagnostic Division, cholesterol‐fast color.
  • 34. Fossati P, Principe L. Serum triglycerides determined colorymetrically with an enzyme of low‐density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1982;28:2077–2080. Medline [PubMed] [Google Scholar]
  • 35. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583–595. Medline [PubMed] [Google Scholar]
  • 36. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502. Medline [PubMed] [Google Scholar]
  • 37. Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RDC. Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 1998; 44:1748–1750. Medline [PubMed] [Google Scholar]
  • 38. Rosner B. Fundamentals of biostatistics, 2nd ed. Boston: PWS; 1986. [Google Scholar]
  • 39. Miserez AR, Schuster H, Chidetti N, Keller U. Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations. Am J Hum Genet 1993;52:808–826. Medline [PMC free article] [PubMed] [Google Scholar]
  • 40. Chaves FJ, Puig O, Garcia‐Sogo M, et al. Seven DNA polymorphism in the LDL receptor gene: Application to the study of familial hypercholesterolemia in Spain. Clin Genet 1996;50:28–35. Medline [DOI] [PubMed] [Google Scholar]
  • 41. Puig O, Chaves FJ, Garcia‐Sogo M, et al. A three‐allelic plymorphic system in exon 12 of the LDL receptor gene is highly informative for segregation analysis of familial hypercholesterolemia in the Spanish population. Clin Genet 1996;50:50–53. Medline [DOI] [PubMed] [Google Scholar]
  • 42. Taylor R, Jeenah M, Seed M, Humphries S. Four DNA polymorphisms in the LDL receptor gene: Their genetic relationship and use in the study of variation at the LDL receptor locus. J Med Genet 1988;25:653–259. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Gudnason V, Zhou T, Thormar K, et al. Detection of the low density lipoprotein receptor gene Pvu II intron 15 polymorphism using the polymerase chain reaction: Association with plasma lipid traits in healthy men and women. Dis Markers 1998;13:209–220. Medline [DOI] [PubMed] [Google Scholar]
  • 44. Russell D, Schneider W, Yamamoto T, Luskey K, Brown M, Goldstein J. Domain map of the LDL receptor: Sequence homology with epidermal growth factor precursor. Cell 1984;37:577–585. Medline [DOI] [PubMed] [Google Scholar]
  • 45. Reshef A, Meiner V, Dann EJ, Granat M, Leitersdorf E. Prenatal diagnosis of familial hypercholesterolemia caused by the “Lebanese” mutation at the low density lipoprotein receptor locus. Hum Genet 1992;89:237–239. Medline [DOI] [PubMed] [Google Scholar]
  • 46. Schuster H, Humphries S, Rauh G, et al. Association of DNA‐haplotypes in the human LDL‐receptor gene with normal serum cholesterol levels. Clin Genet 1990;38:401–409. Medline [DOI] [PubMed] [Google Scholar]
  • 47. Poledne R, Pisa Z, Berg K. Normal genetic variation in the low density lipoprotein receptor (LDLR) locus influences cholesterol levels in children. Clin Genet 1993;43:122–126. Medline [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES